Literature DB >> 8494026

The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view.

P Zucchelli1, A Zuccalà.   

Abstract

The appearance of progressive renal disease in elderly patients with essential hypertension, sometimes irrespective of blood pressure control, is frequently related to the association of hypertension and atheromatous renal disease. This disease may lead to renal failure through a renal artery stenosis and/or chronic microembolization into the kidney. Nonsevere uncomplicated essential hypertension is constantly associated with renal vascular changes that are qualitatively indistinguishable from those related to aging. Notwithstanding the fairly constant presence of so-called benign hypertensive nephrosclerosis in patients with established hypertension, only a subset of these patients show progressive renal damage. Three mechanisms of progression may be at play: (1) a combination of ischemic and hypertensive glomerular mechanisms in some susceptible humans; (2) nonhemodynamic factors such as local immune mechanisms; or (3) the involvement of metabolic abnormalities which favor glomerulosclerosis.

Entities:  

Mesh:

Year:  1993        PMID: 8494026     DOI: 10.1016/0272-6386(93)70100-d

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

Review 1.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Atheroembolic renal disease with rapid progression and fatal outcome.

Authors:  Bernardo Faria; Joana Vidinha; Cátia Pêgo; Jesus Garrido; Sérgio Lemos; Carla Lima; Giovanni Sorbo; Edgar Lorga Gomes; Teresa Carvalho; Paulo Loureiro; Tânia Sousa
Journal:  Clin Exp Nephrol       Date:  2010-11-11       Impact factor: 2.801

3.  Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis.

Authors:  Qiulun Lu; Zejun Ma; Ye Ding; Tatiana Bedarida; Liming Chen; Zhonglin Xie; Ping Song; Ming-Hui Zou
Journal:  Nat Commun       Date:  2019-05-13       Impact factor: 14.919

4.  Does established vascular kidney disease exist?

Authors:  Nicolás Roberto Robles; Francesco Fici; Elif Ari Bakir; Guido Grassi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.